These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment. Lykkesfeldt AE, Larsen SS, Briand P. Int J Cancer; 1995 May 16; 61(4):529-34. PubMed ID: 7759159 [Abstract] [Full Text] [Related]
3. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells. Coopman P, Garcia M, Brünner N, Derocq D, Clarke R, Rochefort H. Int J Cancer; 1994 Jan 15; 56(2):295-300. PubMed ID: 8314314 [Abstract] [Full Text] [Related]
4. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen. Brünner N, Boysen B, Jirus S, Skaar TC, Holst-Hansen C, Lippman J, Frandsen T, Spang-Thomsen M, Fuqua SA, Clarke R. Cancer Res; 1997 Aug 15; 57(16):3486-93. PubMed ID: 9270017 [Abstract] [Full Text] [Related]
6. Effect of estrogen and antiestrogens on cell proliferation and synthesis of secreted proteins in the human breast cancer cell line MCF-7 and a tamoxifen resistant variant subline, AL-1. Lykkesfeldt AE, Sørensen EK. Acta Oncol; 1992 Aug 15; 31(2):131-8. PubMed ID: 1622627 [Abstract] [Full Text] [Related]
7. An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol. Jiang SY, Wolf DM, Yingling JM, Chang C, Jordan VC. Mol Cell Endocrinol; 1992 Dec 15; 90(1):77-86. PubMed ID: 1301400 [Abstract] [Full Text] [Related]
8. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Pink JJ, Jordan VC. Cancer Res; 1996 May 15; 56(10):2321-30. PubMed ID: 8625307 [Abstract] [Full Text] [Related]
12. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells. Weaver CA, Springer PA, Katzenellenbogen BS. Mol Endocrinol; 1988 Oct 15; 2(10):936-45. PubMed ID: 2460749 [Abstract] [Full Text] [Related]
17. Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator. Juncker-Jensen A, Lykkesfeldt AE, Worm J, Ralfkiaer U, Espelund U, Jepsen JS. Growth Horm IGF Res; 2006 Aug 15; 16(4):224-39. PubMed ID: 16893667 [Abstract] [Full Text] [Related]
18. Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations. van Agthoven T, van Agthoven TL, Dekker A, Foekens JA, Dorssers LC. Mol Endocrinol; 1994 Nov 15; 8(11):1474-83. PubMed ID: 7533260 [Abstract] [Full Text] [Related]
19. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation. Zhou-Li F, Albaladejo V, Joly-Pharaboz MO, Nicolas B, Andre J. Endocrinology; 1992 Mar 15; 130(3):1145-52. PubMed ID: 1537281 [Abstract] [Full Text] [Related]
20. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens. Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS. Mol Endocrinol; 1996 Mar 15; 10(3):230-42. PubMed ID: 8833652 [Abstract] [Full Text] [Related] Page: [Next] [New Search]